«I think we will see more of
an impact of those programs in the next few years as more farmers start the transition process (to organic),» says Heilman.
Not exact matches
By focusing on outcomes for Canadians and making evidence - based decisions that are anchored
in meaningful data and indicators, the Government is moving to a culture
of measurement and
impact, and is putting
in place the tools to deliver on priorities, align resources to
programs and activities that deliver real value for Canadians, and provide meaningful information to Canadians and Parliament.
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing
programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development
programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787
program; 4) margin pressures and the potential for additional forward losses on new and maturing
programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases
in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse
impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse
impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the
impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect
of changes
in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging
programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or
impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing
program; 34) the risks
of doing business internationally, including fluctuations
in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Part
of Sessions» argument
in favor
of rescinding the
program was economic; he said it had adversely
impacted native born Americans «It also denied jobs to hundreds
of thousands
of Americans by allowing those same jobs to go to illegal aliens,» he said.
In adopting its Cannabis Equity Program, the City of Oakland made a clear commitment to ensure access and equity in legal cannabis for communities most negatively impacted by the drug wa
In adopting its Cannabis Equity
Program, the City
of Oakland made a clear commitment to ensure access and equity
in legal cannabis for communities most negatively impacted by the drug wa
in legal cannabis for communities most negatively
impacted by the drug war.
Instead, the startup
program should be seen as just one part
of Google's emerging efforts to remake the economic
impact of patents
in the tech industry.
«Taking a look at a country like New Zealand — number four
in the ranking — we can see the
impact of a
program they implemented 10 years ago,» says Farrington.
A team under Airbnb's global head
of social
impact, Kim Rubey, was already working on a
program to house refugee relief workers
in Greece, Macedonia and Serbia, but to address the product challenge, Gebbia formed a new team under his Samara studio that was ultimately spun out and called the Human team.
These forward - looking statements include, among other things, statements about full - year 2018 guidance, project milestones, increased opportunities
in the market, backlog, bids and change orders outstanding, target projects and revenue opportunity pipeline, to the extent these may be viewed as indicators
of future revenues or profitability, the expected
impacts of the F2G
program and progress toward completing the proposed combination with CB&I and the anticipated benefits
of that transaction.
In fact, here are three tips to get an employee volunteer
program (EVP) off the ground, so your startup can grow its
impact right away and make a culture
of service part
of its DNA.
In Michigan, the Michigan Pathways to Better Health (MPBH) program, implemented by the Michigan Public Health Institute and the Michigan Department of Community Health, is using tablet - based checklists to collect demographic information in communities with the greatest health needs and assess behavioral health, and social service factors impacting each patient to get a fuller picture of social determinants of healt
In Michigan, the Michigan Pathways to Better Health (MPBH)
program, implemented by the Michigan Public Health Institute and the Michigan Department
of Community Health, is using tablet - based checklists to collect demographic information
in communities with the greatest health needs and assess behavioral health, and social service factors impacting each patient to get a fuller picture of social determinants of healt
in communities with the greatest health needs and assess behavioral health, and social service factors
impacting each patient to get a fuller picture
of social determinants
of health.
I've observed for some time how CEOs and other executives can't keep their cybersecurity
programs in a silo where only a certain number
of people fully understand and appreciate their
impact.
The good news, according to Pentagon acquisition chief Frank Kendall, is that a range
of measures put
in place over the last half - decade have made a positive
impact on the Pentagon's buying power while trimming costs across a range
of major defense
programs.
In a separate TriNet survey, 76 percent
of respondents said proposed changes to that
program would have a negative
impact on their companies.
In early July, the country's tourism secretary, Enrique de la Madrid, announced the government would implement a trial security program in Los Cabos, Cancun, and Acapulco that month, because those areas «are the destinations that concern us most at the moment because of the impact they have on [Mexico's] image abroad.&raqu
In early July, the country's tourism secretary, Enrique de la Madrid, announced the government would implement a trial security
program in Los Cabos, Cancun, and Acapulco that month, because those areas «are the destinations that concern us most at the moment because of the impact they have on [Mexico's] image abroad.&raqu
in Los Cabos, Cancun, and Acapulco that month, because those areas «are the destinations that concern us most at the moment because
of the
impact they have on [Mexico's] image abroad.»
The failures
of the healthcare system have wide - ranging
impacts, according to Dimon, who said the real problem with the US deficit is the «uncontrolled growth
of our entitlement
programs,» and that
in turn «the core issue underpinning the entitlements problem is healthcare
in the United States.»
In recently commissioned research by Ryerson's Jim Pattison Ethical Leadership
program about the Ethics
of Political Leadership, some disturbing trends about the ethical
impact of the mayor's reign
of error have been highlighted.
That's why we introduced the Recreational Fisheries Conservation Partnerships
Program, which doubled the
impact of every dollar invested
in its first year.
«Every single one
of the businesses [
in the SheEO
program] is motivated by profound social
impact.»
In January, the
program graduates its inaugural class
of four teams, whose creations include a biosignal - tracking wristband; an
impact - monitorinwg mouthguard that can help athletes avoid aggravating head injuries; a tracking device for skateboards; and a robotic toy that teaches kids as young as 4 to code.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount
of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability
of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange
impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Kaplan acknowledges that while we can't technically mistreat artificial intelligence
programs in the same way we are capable
of mistreating other people, how we treat AI
programs may
impact how we treat people.
«
In order to accelerate meaningful corporate and market
impact, many corporations are expanding their CVC unit mandates to include traditional minority investments, majority equity investment more consistent with Growth PE, M&A and internal commercial piloting and incubation
programs; and compensation structures need to keep pace with these changes,» said Heidi Mason, managing partner
of Bell Mason Group and co-founder
of CVI ².
The Comptroller General
of the United States (referred to
in this section as the Comptroller General) shall conduct a study addressing the effectiveness and overall
impact of the following priority review voucher
programs, including any such
programs amended or established by this Act:
In developing the National OCS
Program, which has also been known as a Five Year
Program, the Secretary is required to achieve an appropriate balance among the potential for environmental
impacts, for discovery
of oil and gas, and for adverse effects on the coastal zone.
We're seeing firsthand, the
impact content and influence is having on marketing and have been working with many
of the top B2B brands
in the world to plan, implement and optimize content marketing
programs with highly credible and connected influencers.
NEXT Canada has launched a number
of successful
programs in the past, establishing itself as a leader
in the development
of high
impact entrepreneurs.
Chariot, the commuter shuttle provider owned by Ford, has received a private transit
program permit to operate more safely and, ideally, have less
of an
impact on public transit
in San Francisco.
Direct
program expenses were up $ 1.0 billion (5.5 %), primarily due to the timing
of payments as well as an increase
in federal government employee pension and other future benefit liabilities, reflecting the
impact of lower interest rates.
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the
impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits
of such transactions, including with respect to the Merger; the substantial level
of government regulation over our business and the potential effects
of new laws or regulations or changes
in existing laws or regulations; the outcome
of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation
in government - sponsored
programs such as Medicare; the effectiveness and security
of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts
of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits
of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration
of the businesses
of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion
of management's attention from ongoing business operations and opportunities during the pendency
of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability
of financing, including relating to the proposed Merger; effects on the businesses as a result
of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed
in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section
of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section
of www.express-scripts.com.
In addition to measuring the
impact of your marketing tactics and
programs, account - based attribution enables you to identify opportunities for marketing and sales to come together to drive more revenue.
Funding for mental health care initiatives is an issue specifically identified
in our pre-budget letter to government and our 2017 Provincial Election Platform, given that there is strong evidence that effective
programs can reduce both the economic and health
impacts of these illnesses.
When you speak
of the
programs and people that will be
impacted, instead think
of the reduction
in cancer, the increase
in marine life, the removal
of plastics from the bottled water being sold... the list goes on.
The CNGC, via the CD&A s included
in the Company's annual proxy statements, also already reports to shareholders on an annual basis regarding the relationship between our incentive compensation
programs and the Company's ROI performance and how the Company's ROI performance may have a meaningful
impact on the amount
of compensation our NEOs receive.
Country fund outflows
of $ 21 billion are focused
in a group
of 10 locally - listed China A Shares funds, due to concerns over valuations and the
impact of the Shanghai Hong Kong Stock Connect
program on ETFs.
We also believe our current
programs, initiatives, and partnerships have been evaluated and selected carefully by management to maximize the
impact our Company can have
in contributing to the worldwide reduction
of GHG emissions.
As a continuation
of its ethical sourcing commitment, Starbucks will launch a pilot
program with select coffee farmers
in Costa Rica, Colombia and Rwanda to develop next - level data technology to log and share real - time information along the journey
of coffee beans with the aim
of driving positive
impact to smallholder farmers within its supply chain.
With this thought
in mind, SIE and Morgan Stanley Philanthropy Management joined together at the recent «2016 Conference on Scaling
Impact» to share high - impact programs appealing to families, foundations, philanthropists, and funders, as well as bringing together prominent philanthropists with a shared goal of curing c
Impact» to share high -
impact programs appealing to families, foundations, philanthropists, and funders, as well as bringing together prominent philanthropists with a shared goal of curing c
impact programs appealing to families, foundations, philanthropists, and funders, as well as bringing together prominent philanthropists with a shared goal
of curing cancer.
In a recent report that we developed with Altimeter Group and Traackr, we found that only 11 %
of B2B companies are running an ongoing influencer marketing
program, yet 80 %
of these marketers rate content marketing most
impacted by influencer marketing.
DPS has committed more than $ 28 million through Let's Play since the
program launched
in 2011,
impacting millions
of youth serving organizations across the U.S., as well as Canada, Mexico and the Caribbean.
He's
in charge
of the acceleration team
of Start - Up Chile, through the implementation
of strategies, education and networks for a world - class
program that aims to increase the chances
of success and
impact of entrepreneurs
in Chile.
In addition to pledging a total of $ 3 million in grant funding to recovery and relief efforts to assist pets and pet owners in need, the company's PetSmart Charities philanthropic arm coordinated deliveries of several truckloads of critically needed pet food and pet supplies as part of its Buy A Bag, Give A Meal program to communities deeply impacted by the hurricane
In addition to pledging a total
of $ 3 million
in grant funding to recovery and relief efforts to assist pets and pet owners in need, the company's PetSmart Charities philanthropic arm coordinated deliveries of several truckloads of critically needed pet food and pet supplies as part of its Buy A Bag, Give A Meal program to communities deeply impacted by the hurricane
in grant funding to recovery and relief efforts to assist pets and pet owners
in need, the company's PetSmart Charities philanthropic arm coordinated deliveries of several truckloads of critically needed pet food and pet supplies as part of its Buy A Bag, Give A Meal program to communities deeply impacted by the hurricane
in need, the company's PetSmart Charities philanthropic arm coordinated deliveries
of several truckloads
of critically needed pet food and pet supplies as part
of its Buy A Bag, Give A Meal
program to communities deeply
impacted by the hurricanes.
It might seem astounding that just doing some lead nurturing would have that kind
of impact, but keep
in mind that the Aberdeen Group found that 79 percent
of marketing qualified leads never make it to closing largely because there is no lead nurturing
program in place.
Released
in 2010, this report details the economic
impact estimates
of 10 years» outcomes from the Florida High Tech Corridor Council's investments into its Matching Grant Research
Program.
The immediate
impact of a Real - Time Mindshift can be seen from the reactions to David's recent
programs in very different industries:
Our investments
in new technologies, central repair facilities, and advanced training
programs have created industry - leading practices and capabilities, allowing customers to maximize efficiencies and minimize the environmental
impact of their operations.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services
in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the
impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments
in Venezuela and the
impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits
of its CORE
program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry (R) World (TM); risks related to the collection, storage, transmission, use and disclosure
of confidential and personal information;
Some 5,000 U.K. companies have so far benefited from the ECR
program in terms
of improving their international marketing communications, with a majority (80 %) noting that it has had a positive
impact on their overall profitability.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services
in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the
impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments
in Venezuela and the
impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits
of its CORE
program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure
of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers
of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities
in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice
of providing forward - looking guidance; potential charges relating to the impairment
of intangible assets recorded on BlackBerry's balance sheet; risks as a result
of actions
of activist shareholders; government regulation
of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties
in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.
Other high -
impact stories have followed: After the BBC and BuzzFeed News co-published an investigation into match - fixing
in the upper echelons
of tennis, the sport's major associations launched an independent review
of its anti-corruption
program.